SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-20-000424
Filing Date
2020-06-05
Accepted
2020-06-05 19:41:36
Documents
2
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1628
2 POA attachment_1.htm EX-24 2629
  Complete submission text file 0001192482-20-000424.txt   5814
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACHILLION PHARMACEUTICALS, INC. 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Truitt Joseph (Reporting) CIK: 0001452429 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 20947814